All antiviral articles
-
Business
New Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
-
Research
Synthetic peptide mimics can act as antivirals
Peptoids disrupt enveloped viruses’ lipid membranes as well as targeting fungi and bacteria
-
Research
AI can suggest Covid-19 antivirals from protein sequence alone
IBM model can also find molecules that bind at different sites on target proteins
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
Business
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
Opinion
Letters: January 2022
Readers reminisce, consider the limits of trust and continue the debate on chemical nomenclature
-
Business
Covid-19 antivirals surge forward
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir
-
Business
New antiviral impresses against Covid-19
Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses
-
Opinion
Where are the Covid-19 drugs?
Small molecules appear to be lagging behind development of vaccine and antibody treatments
-
Business
The multi-pronged search for Covid-19 treatments
Drugs that block infection or reduce inflammation will complement vaccine protection
-
Research
Synthetic overhaul for hepatitis C drug could ease manufacturing demands
Chemists hope their five-step synthesis will increase global accessibility of uprifosbuvir and other lifesaving antivirals
-
Opinion
How the pandemic might change drug research
Derek Lowe muses on some positive lessons learned
-
Opinion
Hopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
Opinion
Does the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
Podcast
Remdesivir
Will new clinical trials for Covid-19 give remdesivir a second chance? Ben Valsler introduces the broad-spectrum antiviral that didn’t quite make it as the Ebola drug it was originally planned to be
-
Business
Can existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
Podcast
Amantadine
Katrina Krämer investigates how one of the smallest small molecule drugs around saved Jeanna Giese's life
-
News
India's HIV/Aids law may bring relief to a million people
Legislation aims to tackle stigma of testing and treatment